BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9761786)

  • 1. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
    Minshall RD; Miyagawa K; Chadwick CC; Novy MJ; Hermsmeyer K
    FASEB J; 1998 Oct; 12(13):1419-29. PubMed ID: 9761786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys.
    Minshall RD; Stanczyk FZ; Miyagawa K; Uchida B; Axthelm M; Novy M; Hermsmeyer K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):649-59. PubMed ID: 9467588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ release mechanism of primate drug-induced coronary vasospasm.
    Miyagawa K; Vidgoff J; Hermsmeyer K
    Am J Physiol; 1997 Jun; 272(6 Pt 2):H2645-54. PubMed ID: 9227542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nongenomic vasodilator action of progesterone on primate coronary arteries.
    Minshall RD; Pavcnik D; Browne DL; Hermsmeyer K
    J Appl Physiol (1985); 2002 Feb; 92(2):701-8. PubMed ID: 11796684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys.
    Minshall RD; Pavcnik D; Halushka PV; Hermsmeyer K
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1498-507. PubMed ID: 11557538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
    Mishra RG; Stanczyk FZ; Burry KA; Oparil S; Katzenellenbogen BS; Nealen ML; Katzenellenbogen JA; Hermsmeyer RK
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H295-303. PubMed ID: 16199482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone.
    Hermsmeyer RK; Mishra RG; Pavcnik D; Uchida B; Axthelm MK; Stanczyk FZ; Burry KA; Illingworth DR; Juan C; Nordt FJ
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):955-61. PubMed ID: 15031127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific protein kinase C activity at variable Ca2+ entry during coronary artery contraction by vasoactive eicosanoids.
    Kanashiro CA; Khalil RA
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1110-9. PubMed ID: 10326833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys.
    Hermsmeyer K; Miyagawa K; Kelley ST; Rösch J; Hall AS; Axthelm MK; Greenberg B
    J Am Coll Cardiol; 1997 Mar; 29(3):671-80. PubMed ID: 9060910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C.
    McNair LL; Salamanca DA; Khalil RA
    Hypertension; 2004 Apr; 43(4):897-904. PubMed ID: 14981072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 beta-Estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery.
    Han SZ; Karaki H; Ouchi Y; Akishita M; Orimo H
    Circulation; 1995 May; 91(10):2619-26. PubMed ID: 7743625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen restores postischemic sensitivity to the thromboxane mimetic U46619 in rat pial artery.
    Qin X; Hurn PD; Littleton-Kearney MT
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1041-6. PubMed ID: 15758945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries.
    Teoh H; Quan A; Leung SW; Man RY
    Br J Pharmacol; 2000 Apr; 129(7):1301-8. PubMed ID: 10742284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
    Raafat AM; Hofseth LJ; Haslam SZ
    Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.
    Cogolludo A; Moreno L; Bosca L; Tamargo J; Perez-Vizcaino F
    Circ Res; 2003 Oct; 93(7):656-63. PubMed ID: 12970114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of epsilon-protein kinase C-dependent pathway.
    Dallas A; Khalil RA
    Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1454-63. PubMed ID: 14600078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-independent relaxation to raloxifene in porcine coronary artery.
    Leung HS; Seto SW; Kwan YW; Leung FP; Au AL; Yung LM; Yao X; Huang Y
    Eur J Pharmacol; 2007 Jan; 555(2-3):178-84. PubMed ID: 17113071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.